G8875 HCPCS: Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS G8875: Breast Cancer Diagnosed Preoperatively by Minimally Invasive Biopsy

HCPCS Level II code G8875 indicates a clinician’s preoperative diagnosis of breast cancer established by a minimally invasive biopsy method. Nationally, this distinction is important for marking the diagnostic pathway prior to definitive surgical management, influencing care coordination, prior authorization workflows, and claims processing. The code captures a specific clinical finding rather than a procedure, and it signals that biopsy-based tissue diagnosis has already been achieved before surgery.

Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and how the code is used in billing and administrative workflows. The publication outlines benchmarks where available, highlights relevant policy or coverage considerations from major payers, and explains coding and documentation implications in preoperative breast cancer care.

This summary is intended for a national audience of clinicians, billing professionals, and policy analysts seeking clarity on the purpose and administrative role of HCPCS Level II code G8875. Data not available in the input are identified where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG8875HCPCS Level IIbreast biopsypreoperative diagnosisdiagnostic codingoncology diagnosticsoutpatient servicesambulatory care

Billing Code Overview

HCPCS Level II code G8875 documents when a clinician diagnoses breast cancer preoperatively by a minimally invasive biopsy method. This code represents a diagnostic determination reached before definitive surgical intervention.

Service type: Diagnostic biopsy interpretation and preoperative diagnostic assessment
Typical site of service: Outpatient clinic, breast specialty clinic, or ambulatory surgical center

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 54-year-old woman presents to the breast clinic after an abnormal screening mammogram showing a 1.8 cm irregular spiculated mass in the upper outer quadrant of the right breast. Diagnostic workup includes targeted diagnostic mammography and ultrasound. Sonographic guidance is used to perform a percutaneous core needle biopsy (minimally invasive biopsy) by the breast surgeon or interventional radiologist. Pathology returns invasive ductal carcinoma. The clinician documents the preoperative diagnosis of breast cancer based on the minimally invasive biopsy prior to scheduling definitive surgery (lumpectomy or mastectomy). Typical workflow: initial imaging → image-guided core needle biopsy (local anesthesia) → pathology processing and diagnostic report → multidisciplinary discussion → preoperative diagnosis recorded in the medical record and communicated to surgical team and payors for preauthorization and surgical planning.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work, time, or complexity significantly exceeds usual for associated services during biopsy-related procedures or preparatory evaluation.
`23`	Unusual anesthesia

HCPCS G8656: Lower Leg, Foot or Ankle Residual Impairment Score (<0)

HCPCS-G0140-PRINCIPAL-ILLNESS-NAVIGATION-PEER-SUPPORT

HCPCS G0140: Principal Illness Navigation, Peer Support (60 min/month)

HCPCS-G8718-TOTAL-KTV-GE-1-7-WEEK-DIALYSIS-ADEQUACY

HCPCS G8718: Total Kt/V ≥ 1.7 per Week

HCPCS-G2161-PRIOR-ADVERSE-REACTION-ZOSTER-VACCINE

HCPCS G2161: Prior Adverse Reaction to Zoster Vaccine

HCPCS-G9891-MDPP-EXPANDED-MODEL-SESSION-REPORTING

HCPCS G9891: MDPP Expanded Model Session Reporting

HCPCS-G9712-ANTIBIOTIC-MEDICAL-JUSTIFICATION-DOCUMENTATION

HCPCS G9712: Documentation of Medical Reason for Antibiotic Prescribing

HCPCS-G9761-HOSPICE-UTILIZATION-MEASUREMENT-PERIOD

HCPCS G9761: Patients Using Hospice Services During Measurement Period

HCPCS-G9599-AORTIC-ANEURYSM-6CM-OR-GREATER-CT-MEASUREMENT

HCPCS G9599: Aortic Aneurysm 6.0 cm or Greater on CT

HCPCS-G9745-DOCUMENTED-REASON-NO-BP-SCREENING-OR-FOLLOW-UP

HCPCS G9745: Documented Reason for Not Screening or Recommending Follow-Up for High Blood Pressure

HCPCS-G8549-HEPATITIS-C-QUALITY-ACTIONS-COMPLETE

HCPCS G8549: Completion of Hepatitis C Quality Measures

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RC0000X`	General Surgery	Surgeons performing breast biopsies, lumpectomy, or mastectomy and documenting preoperative diagnosis.
`207RG0100X`	Surgical Oncology	Specialists managing cancer diagnosis and coordinating biopsy and definitive oncologic surgery.
`207PS0010X`	Radiology - Diagnostic	Interventional radiologists or diagnostic radiologists performing image-guided percutaneous breast biopsies.
`363L00000X`	Pathology	Pathologists providing tissue diagnosis that establishes preoperative breast cancer diagnosis.
`208D00000X`	Obstetrics & Gynecology (Breast Surgery focus)	Gynecologic surgeons with breast surgery interest in some practices; less common but relevant in certain settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C50.911`	Malignant neoplasm of unspecified site of right female breast	Primary diagnosis commonly used when invasive breast cancer is confirmed on biopsy and later specified for surgical planning.
`C50.912`	Malignant neoplasm of unspecified site of left female breast	Used when biopsy confirms malignancy in the left breast prior to definitive surgery.
`D05.91`	Unspecified type of noninfiltrating intraductal carcinoma, right breast	Relevant for in situ disease diagnosed by core biopsy establishing preoperative diagnosis.
`D05.92`	Unspecified type of noninfiltrating intraductal carcinoma, left breast	Used for ductal carcinoma in situ on biopsy when preoperative diagnosis is recorded.
`R92.8`	Other nonspecific abnormal findings on diagnostic imaging of breast	Used when imaging triggers biopsy; documents abnormal imaging finding in the diagnostic pathway.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`19083`	Biopsy, breast, with placement of localization device(s) (e.g., clip, seed), when performed, percutaneous, with imaging guidance	Often performed when tissue sampling is obtained and a marker is placed to guide subsequent surgery after a preoperative cancer diagnosis.
`19081`	Biopsy, breast, percutaneous, needle core, using imaging guidance (e.g., stereotactic, ultrasound or MRI)	Commonly used for the minimally invasive diagnostic biopsy that establishes the preoperative diagnosis of breast cancer.
`77012`	CT guidance for needle placement (eg, biopsy, aspiration, injection, localization device placement)	Used when CT-guided needle placement is required for nonstandard lesion locations during the biopsy workflow.
`76942`	Ultrasonic guidance for needle placement (e.g., biopsy, aspiration, injection, localization device)	Frequently reported when ultrasound guidance is used during percutaneous breast biopsy.
`88305`	Level IV surgical pathology, gross and microscopic examination	Typical pathology CPT for core biopsy specimens that yields the definitive histologic diagnosis of breast cancer.

OpenPayer